Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 43Lymphoma, Large B-Cell, Diffuse 35Burkitt Lymphoma 33Lymphoma 26Lymphoma, Follicular 16Rhabdomyosarcoma 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma, B-Cell 12Neuroblastoma 10Medulloblastoma 10Lymphoma, Non-Hodgkin 10Leukemia 10Sarcoma, Ewing 9Leukemia, Biphenotypic, Acute 9Recurrence 8Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 8Neoplasms 8Lymphoma, T-Cell, Peripheral 8Lymphoma, Mantle-Cell 7Lymphoma, B-Cell, Marginal Zone 7Hodgkin Disease 7Wilms Tumor 5Sarcoma 5Retinoblastoma 5Osteosarcoma 4Lymphoproliferative Disorders 4Lymphoma, T-Cell 4Leukemia, Lymphocytic, Chronic, B-Cell 4Ganglioneuroblastoma 4Down Syndrome 4

Interventions

varlilumab 1Vincristine 1Tomography, X-Ray Computed 1Rituximab 1Prednisone 1Nivolumab 1Interferons 1Immunoglobulin G 1Etoposide 1Echocardiography 1EPOCH protocol 1Doxorubicin 1Disulfides 1Cyclophosphamide 1Caves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphomatoid Granulomatosis × Vincristine × 1 year × Clear all
NCT00001379 2025-06-19

Treatment and Natural History Study of Lymphomatoid Granulomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
94 enrolled 20 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡